Abbott’s $25bn St. Jude acquisition would be anti-competitive, says FTC
24-02-2017
FTC orders biggest ever divestiture in Teva Allergan deal
16-09-2016
RiverNorthPhotography / iStockphoto.com
Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Federal Trade Commission, FTC, Maureen Ohlhausen, healthcare, enforcement efforts, competition, antitrust, mergers & acquisitions
